NAGE · Forms 3, 4, 5
Insider trades at Niagen Bioscience, Inc.
No open-market insider buys or sells at Niagen Bioscience, Inc. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Niagen Bioscience, Inc. (NAGE) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for Niagen Bioscience, Inc. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Carlos Luis Lopez | SVP, General Counsel | Award | 2,314 | $2.71 | $6K | Form 4 | |
| Ozan Pamir | Chief Financial Officer | Award | 4,255 | $2.71 | $12K | Form 4 | |
| Robert N Fried | Chief Executive Officer | Award | 1,106 | $2.71 | $3K | Form 4 | |
| Wing Tak Wendy YU | Director | Options or other derivatives | Form 4 | ||||
| Wang Yu Gary Ng | Director | Options or other derivatives | Form 4 | ||||
| Ann Cohen | Director | Options or other derivatives | Form 4 | ||||
| Kristin Patrick | Director | Options or other derivatives | Form 4 | ||||
| Hamed Shahbazi | Director | Options or other derivatives | Form 4 | ||||
| Steven D Rubin | Director | Options or other derivatives | Form 4 | ||||
| Frank L Jaksch Jr | Director | Options or other derivatives | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.